ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2272

Missed Opportunity? Evaluation for Systemic Autoimmune Diseases in Patients with Uveitis May Not be Optimal: 5-Year Analysis of Patients Being Seen in a Tertiary Medical Center

Nancy Harrison1, Swetha Boddeda2, Shweta Kishore2 and Vikas Majithia3, 1Rheumatolody, University of Mississippi Medical Center, Jackson, MS, 2Rheumatology, University of Mississippi Medical Center, Jackson, MS, 3Division of Rheumatology, University of Mississippi Medical Center, Jackson, MS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: systemic illness and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Uveitis is the most common inflammatory eye disease and is frequently associated with secondary systemic autoimmune diseases (SSAID) excluding infection in 40-55% of cases. This analysis was undertaken to assess the diagnostic prevalence of patients of these disorders in patients with uveitis being evaluated by ophthalmology in a tertiary referral center.

Methods: Patients aged 18 years and older with uveitis, diagnosed and followed by ophthalmology from January 2013 to March 2018 were identified. By using the patient cohort explorer, an online visit processing tool, a search for diagnostic codes for uveitis (91 separate ICD-9 and ICD-10 codes) was performed. Individual searches for commonly associated SSAID were further done using ICD-9 and 10 codes to sub-categorize these patients. The search results were cross-referenced by running three additional data searches including medications administration, laboratory and imaging evaluation, and referral to rheumatology. Diagnostic prevalence was calculated and compared to historical data.

Results: There was a total of 1096 patient with uveitis. The majority of patients were female (67%). There was a high prevalence of smoking (37%) and the prevalence of uveitis increased with each decade of life. Only 17% of the cases had a concomitant diagnosis or evaluation for a SSAID, 22% had a diagnosis of an underlying infectious cause and only 1% due to malignancy.  Table 1 shows the demographic data and relative frequency of prevalence in these disorders. Non-specific connective tissue disease was the most common diagnosis in SSAID, followed by sarcoidosis and vasculitis. Seronegative spondyloarthritides were only diagnosed in 18 patients (1.6%). HLA-B27 was only checked in 67 patients (6.1%) with 50% being positive. 

Conclusion: Evaluation for and prevalence of systemic disease associated with uveitis was significantly lower (17%) than what was expected historically (40-55%). Even though this data is limited by the lack of individual review, the data obtained showed similar results through 4 different algorithmic searches. Smoking, a known risk factor for inflammation, was found at a higher prevalence than the general population, and there was an increase in the prevalence of uveitis with older age till 70 years. These data suggest that, despite overwhelming evidence, patients with uveitis may not be adequately evaluated for these systemic diseases. Strategies to improve education and perhaps targeted diagnostic algorithms may improve the detection of secondary systemic diseases.

References:

1.     Rosenbaum JT. Uveitis. An internist’s view. Arch Internal Med 1989;149(5):1173-6.

2.     Henderly DE, Genstler AJ, Smith RE et al. Changing patterns of uveitis. Am J Ophthalmol 1987;103(2):131-6.

3.     Buitenhuis HJ, Meenken C, Brinkman CJ, et al. Uveitis and systemic disease. Br J Ophthalmol 1992;76(3):137-41.


Disclosure: N. Harrison, None; S. Boddeda, None; S. Kishore, None; V. Majithia, None.

To cite this abstract in AMA style:

Harrison N, Boddeda S, Kishore S, Majithia V. Missed Opportunity? Evaluation for Systemic Autoimmune Diseases in Patients with Uveitis May Not be Optimal: 5-Year Analysis of Patients Being Seen in a Tertiary Medical Center [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/missed-opportunity-evaluation-for-systemic-autoimmune-diseases-in-patients-with-uveitis-may-not-be-optimal-5-year-analysis-of-patients-being-seen-in-a-tertiary-medical-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/missed-opportunity-evaluation-for-systemic-autoimmune-diseases-in-patients-with-uveitis-may-not-be-optimal-5-year-analysis-of-patients-being-seen-in-a-tertiary-medical-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology